Novo Nordisk Faces Mounting Challenges on Pricing and Pipeline
Novo Nordisk slashes US prices for Ozempic, Wegovy, and Rybelsus to $675/month in 2027. Its new obesity drug,…
Maersk Disappoints Investors, Points to Continued Challenges in Shipping
Despite reporting better than expected third quarter results and narrowing the range for its yearly income estimate,…